News | April 24, 2014

Global Biopsy Devices Market Value to Grow Moderately by 2019

April 24, 2014 — The global biopsy devices market value will increase at a modest rate over the coming years, climbing from $506.4 million in 2013 to $602.4 million by 2019, at a compound annual growth rate (CAGR) of 2.93%, forecasts research and consulting firm GlobalData.

According to the company’s latest report, MediPoint: Biopsy Devices - Global Analysis and Market Forecasts, the biopsy devices market in emerging economies, such as China, India and Brazil, will increase at much higher CAGRS than the global rate, reaching shares of 24%, 10% and 6% by 2019, respectively.

Despite the modest global growth, several barriers are dampening the potential adoption of biopsy devices within a number of markets. Notably in the United States, reimbursement for image-guided breast biopsies has undergone drastic cuts, which GlobalData expects will have a significant effect on the adoption of more expensive vacuum-assisted biopsy (VAB) devices.

Joseph Gregory, GlobalData’s analyst covering surgical devices, said: “Additionally, routine screening for prostate cancer and breast cancer has come under scrutiny, as sophisticated clinical trials reveal that these interventions have a minimal impact on the cancer related mortality. This is a long-term setback for the adoption of biopsy devices in diagnosing these cancers, given that these criticisms could curb adoption of routine screening.”

While these challenges are likely to affect the biopsy devices market, GlobalData believes that current and future players can still position themselves to obtain a competitive advantage.

“The major European countries have general mass-screening programs for breast cancer detection and will be increasing their adoption of VAB devices over the forecast period. Additionally, the emerging economies are increasing their access to healthcare resources and showing a preference for more expensive core needle biopsy devices over fine needle aspiration devices,” Gregory concluded.

For more information: www.globaldata.com/QuotingGlobalData.aspx

Related Content

Synergy Radiology Associates Employs UroNav Fusion Biopsy System for Better Prostate Cancer Diagnosis
News | Biopsy Systems | July 17, 2017
Radiologists from Synergy Radiology Associates (SRA) in Houston are using the power of 3-D medical imaging and...
Analogic, bkFusion, bk3000, MRI-ultrasound fusion, prostate biopsy, EAU 2017
News | Biopsy Systems | March 30, 2017
March 30, 2017 — Analogic Corp.
Karmanos Cancer Institute, UroNav Fusion Biopsy System, prostate cancer
News | Biopsy Systems | March 23, 2017
March 23, 2017 — Urology specialists at the Barbara Ann Karmanos Cancer Institute (Detroit) have begun using the UroN
Exact Imaging, Health Canada approval, ExactVu micro-ultrasound system, prostate biopsies, Sunnybrook Health Sciences Centre, Gregory Czarnota
News | Biopsy Systems | March 16, 2017
March 16, 2017 — Exact Imaging has received Health Canada approval and the corresponding medical device license (#986
Hologic, ECR 2017, breast cancer screening solutions, Affirm prone biopsy system

The Affirm prone biopsy system. Image courtesy of Hologic.

News | Breast Imaging | March 14, 2017
Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new...
MIM Software, BK Ultrasound, bkFusion, MRI Fusion Biopsy System, prostate cancer, RSNA 2016
Technology | Fusion Imaging Software | January 03, 2017
MIM Software Inc. announced in November the commercial introduction of its MRI (magnetic resonance imaging) Prostate...
Sponsored Content | Videos | Women's Health | November 16, 2016
The purpose of this exploratory video roundtable is to examine the state of breast biopsies today and to communicate...
stereotactic breast imaging

This image shows a 52-year-old patient with benign calcifications in her pre-stereotactic breast biopsy screening.

Feature | Breast Biopsy Systems | November 01, 2016 | By Laura Shepardson, M.D.
Recently, I was invited to participate in a...
News | Biopsy Systems | August 25, 2016
Dune Medical Devices has been selected as one of the few recipients of a European Union Horizon 2020 research grant to...
News | X-Ray | August 12, 2016
August 10,  2016 —Kubtec is helping with with an anthropologic imaging study of dried fetal skulls. 
Overlay Init